Infection control sales will grow through 2036, led by non-woven disposable at 39.2% of the product segment in 2026, driven by infection prevention protocols and single-use compliance mandates in clinical settings. The market was valued at USD 259.1 billion in 2025 and is expected to be worth USD 517.98 billion by 2036.